Advertisement

Search Results for "glaxosmithkline"

Forbes List Logo
GlaxoSmithKline takes its medicines: How Andrew Witty patched up the sick drugmaker
Andrew Witty inherited a drugmaker sick with scandal and spent the next eight years patching up his patient. GlaxoSmithKline may finally be well again
ByMatthew Herper
Titans of the North
BySourav Majumdar
GSK Pharma's Billion-Dollar Buyback
BySamar Srivastava,Salil Panchal
A Shot of India: The Vaccine Market
BySeema Singh

Latest News

RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Synthetic Data: The new backbone of next gen cybersecurity
ByIIM Calcutta
Advertisement
Advertisement

On Everyone’s Radar

Advertisement